Evaluation of Security and Effects of Domestic Tropisetron Hydrochloride on Cisplatin-induced Nausea and Vomiting

黄海辉,陈世旭,张艳玲,邹岚,胡绍毅,边志衡,梁后杰

DOI: https://doi.org/10.3969/j.issn.1671-7171.2005.06.025

2005-01-01

Abstract:[Objective]To compare the security and efficacy between domestic tropisetron hydrochloride and granisetron hydrochloride in prevention of cisplatin-induced anorexia, nausea and vomiting.[Methods]Randomized, double-blind and parallel controlled clinical trial was performed. Forty-eight cancer patients receiving chemotherapy containing cisplatin were randomly divided into two groups. One group received a preventive usage of tropisetron hydrochloride one day before chemotherapy, 5 mg/d for 7 continuous days. Another group received a preventive usage of granisetron hydrochloride one day before chemotherapy, 3 mg/d for 7 continuous days. The targets of security and adverse effects such as anorexia, nausea, and vomiting during therapy were observed.[Results]There was no significant difference between the two groups in respect of targets of security and adverse effects( P 0.05).[Conclusion]There are similar efficacy and security between domestic tropisetron hydrochloride and granisetron hydrochloride in prevention of cisplatin-induced anorexia, nausea, and vomiting.